ZimVie (ZIMV) Competitors $13.60 +0.08 (+0.59%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZIMV vs. MDXG, ESTA, BLFS, PLSE, AORT, EMBC, CBLL, LQDA, EYE, and BVSShould you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), Liquidia (LQDA), National Vision (EYE), and Bioventus (BVS). These companies are all part of the "medical equipment" industry. ZimVie vs. MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia National Vision Bioventus MiMedx Group (NASDAQ:MDXG) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, community ranking, valuation, risk and analyst recommendations. Which has preferable valuation and earnings, MDXG or ZIMV? MiMedx Group has higher earnings, but lower revenue than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$342.80M3.90$58.23M$0.5516.55ZimVie$451.29M0.83-$393.28M-$13.11-1.04 Does the media favor MDXG or ZIMV? In the previous week, MiMedx Group had 2 more articles in the media than ZimVie. MarketBeat recorded 2 mentions for MiMedx Group and 0 mentions for ZimVie. MiMedx Group's average media sentiment score of 0.20 beat ZimVie's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the media. Company Overall Sentiment MiMedx Group Neutral ZimVie Neutral Is MDXG or ZIMV more profitable? MiMedx Group has a net margin of 23.86% compared to ZimVie's net margin of -77.31%. MiMedx Group's return on equity of 26.21% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group23.86% 26.21% 18.15% ZimVie -77.31%2.90%1.17% Does the MarketBeat Community believe in MDXG or ZIMV? MiMedx Group received 42 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 81.82% of users gave MiMedx Group an outperform vote while only 18.75% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformMiMedx GroupOutperform Votes4581.82% Underperform Votes1018.18%ZimVieOutperform Votes318.75%Underperform Votes1381.25% Do analysts recommend MDXG or ZIMV? MiMedx Group currently has a consensus price target of $12.00, suggesting a potential upside of 31.87%. ZimVie has a consensus price target of $19.50, suggesting a potential upside of 43.38%. Given ZimVie's higher probable upside, analysts plainly believe ZimVie is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00ZimVie 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders believe in MDXG or ZIMV? 79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 95.6% of ZimVie shares are held by institutional investors. 1.3% of MiMedx Group shares are held by company insiders. Comparatively, 3.0% of ZimVie shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, MDXG or ZIMV? MiMedx Group has a beta of 1.98, indicating that its share price is 98% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500. SummaryMiMedx Group beats ZimVie on 13 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIMV vs. The Competition Export to ExcelMetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$375.35M$3.80B$5.13B$9.08BDividend YieldN/A1.75%4.93%4.22%P/E Ratio-1.0436.7889.6617.18Price / Sales0.831.511,115.28116.98Price / Cash2.8611.1942.8237.86Price / Book0.881.054.794.78Net Income-$393.28M-$33.08M$120.04M$225.60M7 Day Performance-0.95%-0.60%-1.91%-1.23%1 Month Performance-1.02%-1.91%11.48%3.36%1 Year Performance-22.68%115.25%30.60%16.60% ZimVie Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIMVZimVie2.3654 of 5 stars$13.60+0.6%$19.50+43.4%-20.6%$375.35M$451.29M-1.042,600MDXGMiMedx Group2.8123 of 5 stars$9.45+3.2%$12.00+27.0%+1.7%$1.39B$342.80M16.65895ESTAEstablishment Labs2.5211 of 5 stars$46.64+1.4%$60.60+29.9%+73.3%$1.31B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2602 of 5 stars$27.32+2.3%$28.29+3.5%+79.4%$1.27B$146.96M-25.19409Analyst ForecastInsider TradeNews CoveragePLSEPulse Biosciences1.8256 of 5 stars$20.32+15.1%N/A+56.3%$1.25B$700,000.000.00140Insider TradeNews CoverageAORTArtivion2.2159 of 5 stars$29.08+0.5%$31.80+9.4%+59.5%$1.22B$384.90M-1,446.501,500EMBCEmbecta3.7712 of 5 stars$19.87+1.8%$23.00+15.8%+13.5%$1.16B$1.12B14.712,200Short Interest ↓CBLLCeriBellN/A$29.05-0.6%$32.60+12.2%N/A$1.04B$60.04M0.00N/ALQDALiquidia3.4225 of 5 stars$11.03+1.0%$24.00+117.6%+3.7%$933.55M$15.61M-6.7050Analyst ForecastNews CoveragePositive NewsEYENational Vision3.0651 of 5 stars$11.53+1.1%$14.00+21.4%-41.2%$907.99M$2.13B-57.0513,998Analyst RevisionNews CoveragePositive NewsBVSBioventus3.6161 of 5 stars$11.18+1.4%$16.00+43.1%+104.8%$907.31M$555.06M-18.081,200Analyst UpgradePositive News Related Companies and Tools Related Companies MiMedx Group Competitors Establishment Labs Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Artivion Competitors Embecta Competitors CeriBell Competitors Liquidia Competitors National Vision Competitors Bioventus Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZIMV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZimVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZIMV Stock Alerts